Anlon Healthcare Limited (AHCL) — Announcement

· NSE Neutral
📢 Key Event
Chairman and Managing Director participated in a podcast interview with Sumit Mehrotra on July 6, 2026.
💡 Investor Takeaway
The interview provides insight into management's view of the company's strategy and outlook but does not contain new financial data or material updates.

Anlon Healthcare Limited disclosed that Chairman and Managing Director Punitkumar Rasadia participated in a July 6, 2026 interview with former CNBCAWaz anchor Sumit Mehrotra, discussing business performance, industry outlook, operational updates, growth strategy, capital expenditure, financial guidance, acquisition/disinvestment plans, and capacity expansion. The discussion was shared via YouTube, Facebook, Instagram, X, and LinkedIn links. No unpublished price sensitive information was conveyed, and the filing requests exchange record-keeping.

📄 View Original Announcement (PDF)

About Anlon Healthcare Limited (AHCL)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹709.57 Cr

View full AHCL stock details →

📡 Get AI alerts when AHCL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AHCL — Free

📊 More AHCL filings

See all AHCL filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when AHCL files new disclosures

Track AHCL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AHCL — Free

Free account · 2 AI queries/day